Rapidteg Teg-Act Test
Activated Whole Blood Clotting Time. 510(k) K062604, from Haemoscope Corp. (Niles, IL). Product code JBP, class 2.
As of Nov 19, 2026, K062604 is an FDA 510(k) held by Haemoscope Corp., substantially equivalent on Jan 31, 2007 after 152 days, with no recalls tied to it in FDA's recall database.
- Review time: 152 days
- Recalls: 0
- Cited as a predicate by: 1 device
The RapidTEG™ TEG®-ACT Test is a quantitative in vitro diagnostic test intended to monitor heparin anticoagulation in adult patients. It is intended for the use with the Thrombelastograph® (TEG®) Hemostasis System.
- Constellation Vision SystemK101285 · Alcon Manufacturing, Ltd. · Nov 12, 2010
- Sonoclot Coagulation & Platelet Function Analyzer System with Sonoclot ViewerK223635 · Sienco, Inc. · Jan 4, 2023
- Type
- Traditional
- Received
- Sep 1, 2006
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7140
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files